Search Reset All Therapy AreasAge-Related Macular DegenerationAsthmaBreast CancerCardiovascularHodgkin’s LymphomaMalignant MelanomaMigraineMultiple MyelomaMultiple SclerosisNeurologyNon-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaOncologyOphthalmologyOsteoarthritic PainOsteoarthritisParkinson's DiseasePsoriasisPsoriatic ArthritisRheumatoid ArthritisUlcerative Colitis All ProductsBiosimilarsChina In-DepthCurrent TreatmentEmerging TherapiesEpidemiologyProductSpecial Topics / OtherTreatment Algorithms: Claims Data AnalysisUnmet Need All GeographyChileUS All Years20222020201920182017201620152014 Previous12345Next March 7, 2017 Multiple Myeloma | Emerging Therapies | Darzalex/Empliciti (Wave 3) | US | 2017 February 11, 2017 Multiple Sclerosis | Emerging Therapies | Zinbryta (daclizumab) | US | Wave 3 | 2017 December 8, 2016 Atopic Dermatitis | Emerging Therapies | Dupixent (dupilumab) | US | Wave 2 | 2017 December 7, 2016 Multiple Sclerosis | Emerging Therapies | Zinbryta (daclizumab) | US | Wave 1 | 2016 August 31, 2016 Multiple Myeloma | Emerging Therapies | Darzalex/Empliciti (Wave 2) | US | 2016 August 10, 2016 Asthma | Emerging Therapies | Nucala (mepolizumab) | US | Wave 2 | 2016 July 25, 2016 Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia | Emerging Therapies | Venclexta (venetoclax) | US | Wave 1 | 2016 June 14, 2016 Psoriasis | Emerging Therapies | Cosentyx (secukinumab) | US | Wave 3 | 2016 April 25, 2016 Breast Cancer | Emerging Therapies | Ibrance (palbociclib) | US | Wave 3 | 2016 March 23, 2016 Asthma | Emerging Therapies | Nucala (mepolizumab) | US | Wave 1 | 2016 March 14, 2016 Multiple Myeloma | Emerging Therapies | Darzalex/Empliciti (Wave 1) | US | 2016 February 24, 2016 Multiple Sclerosis | Emerging Therapies | Lemtrada (alemtuzumab) | US | Wave 4 | 2016 February 10, 2016 Asthma | Emerging Therapies | Nucala (mepolizumab) | US | Wave 3 | 2017 December 4, 2015 Malignant Melanoma | Emerging Therapies | Keytruda (pembrolizumab) | US | Wave 3 | 2015 November 24, 2015 Psoriasis | Emerging Therapies | Cosentyx (secukinumab) | US | Wave 2 Previous12345Next